Table 3.
Stage | Sensitivity (%) at 80% specificity |
|
---|---|---|
4-BM | 5-BM | |
I (n = 52) | 52 | 52 |
II (n = 19) | 63 | 53 |
III (n = 58) | 67 | 71 |
IV (n = 26) | 85 | 85 |
Adenocarcinoma (n = 74) | 70 | 68 |
Squamous (61) | 57 | 59 |
SCLC (n = 13) | 62 | 69 |
Abbreviations: BM, biomarker; SCLC, small cell lung cancer.